Literature DB >> 11475385

An off-the-shelf help list: a comprehensive catalog of preference scores from published cost-utility analyses.

C M Bell1, R H Chapman, P W Stone, E A Sandberg, P J Neumann.   

Abstract

PURPOSE: The Panel on Cost-Effectiveness in Health and Medicine recommends an organized collection of preference measure values for health states that can be used in costutility analyses (CUAs). The authors sought to construct a catalog of preference scores from published CUAs, organize the catalog by clinical categories, and identify methods of preference score assessment.
METHOD: The authors systematically searched Medline and other databases to identify original CUAs published through 1997. Information was abstracted on the health state descriptions, corresponding preference scores, method of preference score elicitation, and the source of the estimate.
RESULTS: Two hundred twenty-eight CUAs were appraised. The authors found 949 health states and corresponding preference scores. Most frequently, health states pertained to the circulatory system (21.7%), health states were valued by experts (35.8%), and values were derived through community-based preference scores (23.5%).
CONCLUSION: A catalog of preference scores for health states can be constructed. The catalog (http://www.hsph.harvard.edu/organizations/hcra/cuadatabase/ intro.html) may provide a useful reference tool for producers and consumers of CUAs but also underscores the methodologic variation and inconsistencies present in the field.

Entities:  

Mesh:

Year:  2001        PMID: 11475385     DOI: 10.1177/0272989X0102100404

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  18 in total

1.  Using the effect size to model change in preference values from descriptive health status.

Authors:  Kristy Sanderson; Gavin Andrews; Justine Corry; Helen Lapsley
Journal:  Qual Life Res       Date:  2004-09       Impact factor: 4.147

2.  Neck pain patients' preference scores for their current health.

Authors:  Gabrielle van der Velde; Sheilah Hogg-Johnson; Ahmed M Bayoumi; Pierre Côté; Hilary Llewellyn-Thomas; Eric L Hurwitz; Murray Krahn
Journal:  Qual Life Res       Date:  2010-03-27       Impact factor: 4.147

3.  Preference-Based EQ-5D index scores for chronic conditions in the United States.

Authors:  Patrick W Sullivan; Vahram Ghushchyan
Journal:  Med Decis Making       Date:  2006 Jul-Aug       Impact factor: 2.583

4.  Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample.

Authors:  Patrick W Sullivan; Vahram Ghushchyan
Journal:  Med Decis Making       Date:  2006 Jul-Aug       Impact factor: 2.583

5.  Measuring preferences for cost-utility analysis: how choice of method may influence decision-making.

Authors:  Christine M McDonough; Anna N A Tosteson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 6.  Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches.

Authors:  Sun-Young Kim; Sue J Goldie
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

7.  The use of QALY weights for QALY calculations: a review of industry submissions requesting listing on the Australian Pharmaceutical Benefits Scheme 2002-4.

Authors:  Paul A Scuffham; Jennifer A Whitty; Andrew Mitchell; Rosalie Viney
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

8.  Economic efficiency of genetic screening to inform the use of abacavir sulfate in the treatment of HIV.

Authors:  Teresa L Kauf; Raymond A Farkouh; Stephanie R Earnshaw; Maria E Watson; Penny Maroudas; Mike G Chambers
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 9.  A review of health-utility data for osteoarthritis: implications for clinical trial-based evaluation.

Authors:  Hirsch S Ruchlin; Ralph P Insinga
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

10.  Single-dose versus multiple-dose antibiotic prophylaxis for the surgical treatment of closed fractures.

Authors:  Gerard P Slobogean; Peter J O'Brien; Carmen A Brauer
Journal:  Acta Orthop       Date:  2010-04       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.